Phase II Trial of Stereotactic Body Radiotherapy Followed by Ipilimumab in Treating Patients With Stage IV Melanoma

Clinical Trial ID NCT01970527

PubWeight™ 6.18‹?›

🔗 Visit the ClinicalTrials.gov page for NCT01970527

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Radical irradiation of extracranial oligometastases. J Clin Oncol 2014 1.07
2 Combinations of immunotherapy and radiation in cancer therapy. Front Oncol 2014 1.01
3 Cytotoxic T lymphocyte antigen-4 and immune checkpoint blockade. J Clin Invest 2015 0.98
4 In situ vaccination by radiotherapy to improve responses to anti-CTLA-4 treatment. Vaccine 2015 0.92
5 Current clinical trials testing the combination of immunotherapy with radiotherapy. J Immunother Cancer 2016 0.81
6 Immune checkpoint and inflammation as therapeutic targets in pancreatic carcinoma. World J Gastroenterol 2016 0.75
7 Ipilimumab (Anti-Ctla-4 Mab) in the treatment of metastatic melanoma: Effectiveness and toxicity management. Hum Vaccin Immunother 2016 0.75
Next 100